ELEVEN BIOTHERAPEUTICS INC - COM (EBIO)

CUSIP: 286221106

Q3 2015 13F Holders as of 30 Sep 2015

Type / Class
Equity / COM
Total 13F shares
14,234,741
Share change
+44,681
Total reported value
$34,304,000
Price per share
$2.41
Number of holders
25
Value change
-$364,289
Number of buys
14
Number of sells
23

Quarterly Holders Quick Answers

What is CUSIP 286221106?
CUSIP 286221106 identifies EBIO - ELEVEN BIOTHERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ELEVEN BIOTHERAPEUTICS INC - COM (EBIO) as of Q3 2015

As of 30 Sep 2015, ELEVEN BIOTHERAPEUTICS INC - COM (EBIO) was held by 25 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 14,234,741 shares. The largest 10 holders included Third Rock Ventures, LLC, FMR LLC, FRANKLIN RESOURCES INC, Flagship Ventures 2007 General Partner LLC, Redmile Group, LLC, FEDERATED INVESTORS INC /PA/, VANGUARD GROUP INC, Rotella Capital Management, Inc., SABBY MANAGEMENT, LLC, and BlackRock Institutional Trust Company, N.A.. This page lists 25 institutional shareholders reporting positions in this security for the Q3 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.